Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus

We assessed the glycaemic durability with early combination (EC; vildagliptin+metformin [MET], n=22) versus MET monotherapy (n=17), among newly-diagnosed type 2 diabetes mellitus (T2DM) enrolled (between 2012 and 2014) in the VERIFY study from Korea (n=39). Primary endpoint was time to initial treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Soon-Jib, Chang, Sang-Ah, Sohn, Tae Seo, Kwon, Hyuk-Sang, Lee, Jong Min, Moon, Sungdae, Proot, Pieter, Paldánius, Päivi M, Yoon, Kun Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640145/
https://www.ncbi.nlm.nih.gov/pubmed/33176094
http://dx.doi.org/10.4093/dmj.2020.0173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640145/
https://www.ncbi.nlm.nih.gov/pubmed/33176094
http://dx.doi.org/10.4093/dmj.2020.0173

Ejemplares similares